Safety and Efficacy Study of IMSA101 in Refractory Malignancies
Clinical trial NCT04020185 · COMPLETED
Trial details
- NCT number
- NCT04020185
- Sponsor
- ImmuneSensor Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-23
- Primary completion
- 2023-09-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.